|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2005-6-3
|
|
pubmed:abstractText |
The polymorphic enzyme cytochrome P450 2C19 affects omeprazole metabolism. This influence on metabolism might affect serum gastrin levels, and safety, during long-term treatment of reflux oesophagitis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
pubmed-author:AoyamaNN,
pubmed-author:ArakawaTT,
pubmed-author:ChidaNN,
pubmed-author:FujimotoKK,
pubmed-author:HamadaSS,
pubmed-author:HoshinaKK,
pubmed-author:InoueMM,
pubmed-author:KawaharaYY,
pubmed-author:KondoKK,
pubmed-author:MaekawaTT,
pubmed-author:MinaHH,
pubmed-author:MitachiYY,
pubmed-author:NagaiTT,
pubmed-author:NakajimaMM,
pubmed-author:OhkusaTT,
pubmed-author:SatoNN,
pubmed-author:SenzEE,
pubmed-author:ShimataniTT,
pubmed-author:TadokoroKK,
pubmed-author:YoshidaNN
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1331-9
|
|
pubmed:dateRevised |
2007-5-10
|
|
pubmed:meshHeading |
pubmed-meshheading:15932363-Adult,
pubmed-meshheading:15932363-Aged,
pubmed-meshheading:15932363-Anti-Ulcer Agents,
pubmed-meshheading:15932363-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:15932363-Esophagitis, Peptic,
pubmed-meshheading:15932363-Female,
pubmed-meshheading:15932363-Gastrins,
pubmed-meshheading:15932363-Gastroesophageal Reflux,
pubmed-meshheading:15932363-Genotype,
pubmed-meshheading:15932363-Heterozygote,
pubmed-meshheading:15932363-Homozygote,
pubmed-meshheading:15932363-Humans,
pubmed-meshheading:15932363-Male,
pubmed-meshheading:15932363-Middle Aged,
pubmed-meshheading:15932363-Mixed Function Oxygenases,
pubmed-meshheading:15932363-Omeprazole,
pubmed-meshheading:15932363-Polymorphism, Genetic,
pubmed-meshheading:15932363-Recurrence,
pubmed-meshheading:15932363-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis.
|
|
pubmed:affiliation |
Juntendo University School of Medicine, Hongo, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
